BioHarvest Sciences Inc.: shareholders and insiders

BHSTNASDAQHealthcare · Pharmaceutical Preparations

Price

$1.32

November 19, 2026Market cap $30M

What Ploutos Investor adds for BioHarvest Sciences

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 3 fiscal years, from 2023
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

Sorry, we do not have enough data

for purchases and sales by BioHarvest Sciences's insiders

Why?

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

0 Holders over 5%Feb 12, 2025 Latest filing

Nobody reports more than 5% today: those who filed have since fallen to 5% or less.

Fell to 5% or less (1)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Rakib Vivien0.00%Feb 12, 202513G

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter-30%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 0.40% of its shares outstanding were held short, -8.9% since the report before.

Shares held short
90.2K
0.40%
Since the report before99.0K on Sep 30, 2026
-8.9%
5.1
17.6K
Report date
Oct 15, 2026
  • Nov 15, 2024: Shares held short 1,572
  • Nov 29, 2024: Shares held short 10.6K
  • Dec 13, 2024: Shares held short 6,078
  • Dec 31, 2024: Shares held short 9,114
  • Jan 15, 2025: Shares held short 10.8K
  • Jan 31, 2025: Shares held short 5,837
  • Feb 14, 2025: Shares held short 9,821
  • Feb 28, 2025: Shares held short 3,193
  • Mar 14, 2025: Shares held short 4,609
  • Mar 31, 2025: Shares held short 6,581
  • Apr 15, 2025: Shares held short 3,195
  • Apr 30, 2025: Shares held short 25.9K
  • May 15, 2025: Shares held short 23.9K
  • May 30, 2025: Shares held short 14.0K
  • Jun 13, 2025: Shares held short 13.8K
  • Jun 30, 2025: Shares held short 13.6K
  • Jul 15, 2025: Shares held short 16.5K
  • Jul 31, 2025: Shares held short 15.7K
  • Aug 15, 2025: Shares held short 16.0K
  • Aug 29, 2025: Shares held short 16.4K
  • Sep 15, 2025: Shares held short 15.6K
  • Sep 30, 2025: Shares held short 28.7K
  • Oct 15, 2025: Shares held short 50.8K
  • Oct 31, 2025: Shares held short 47.1K
  • Nov 14, 2025: Shares held short 69.1K
  • Nov 28, 2025: Shares held short 70.5K
  • Dec 15, 2025: Shares held short 33.2K
  • Dec 31, 2025: Shares held short 64.0K
  • Jan 15, 2026: Shares held short 61.1K
  • Jan 30, 2026: Shares held short 61.9K
  • Feb 13, 2026: Shares held short 62.8K
  • Feb 27, 2026: Shares held short 69.3K
  • Mar 13, 2026: Shares held short 62.0K
  • Mar 31, 2026: Shares held short 64.9K
  • Apr 15, 2026: Shares held short 65.3K
  • Apr 30, 2026: Shares held short 64.8K
  • May 15, 2026: Shares held short 66.4K
  • May 29, 2026: Shares held short 71.5K
  • Jun 15, 2026: Shares held short 67.0K
  • Jun 30, 2026: Shares held short 72.0K
  • Jul 15, 2026: Shares held short 72.0K
  • Jul 31, 2026: Shares held short 72.5K
  • Aug 14, 2026: Shares held short 73.0K
  • Aug 31, 2026: Shares held short 73.9K
  • Sep 15, 2026: Shares held short 95.4K
  • Sep 30, 2026: Shares held short 99.0K
  • Oct 15, 2026: Shares held short 90.2K

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading45.7% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 45.7% of the shares in the reported trades were short sales, against 49.8% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
45.7%
The 14 beforeOct 13, 2026 – Oct 30, 2026
49.8%
Change
-4.1 pts
Short sales a dayon average, of 14.9K shares
6,794
More than atof 3,666 US-listed companies, same days
34%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 74.5%
  • Oct 14, 2026: Short sales 78.9%
  • Oct 15, 2026: Short sales 51%
  • Oct 16, 2026: Short sales 34.2%
  • Oct 19, 2026: Short sales 57.5%
  • Oct 20, 2026: Short sales 43.4%
  • Oct 21, 2026: Short sales 72.9%
  • Oct 22, 2026: Short sales 57%
  • Oct 23, 2026: Short sales 32.7%
  • Oct 26, 2026: Short sales 57.1%
  • Oct 27, 2026: Short sales 23.4%
  • Oct 28, 2026: Short sales 0.3%
  • Oct 29, 2026: Short sales 74.5%
  • Oct 30, 2026: Short sales 42.1%
  • Nov 2, 2026: Short sales 39.1%
  • Nov 3, 2026: Short sales 1.8%
  • Nov 4, 2026: Short sales 90.4%
  • Nov 5, 2026: Short sales 46.4%
  • Nov 6, 2026: Short sales 25.9%
  • Nov 9, 2026: Short sales 38.9%
  • Nov 10, 2026: Short sales 48.8%
  • Nov 11, 2026: Short sales 58.8%
  • Nov 12, 2026: Short sales 49.6%
  • Nov 13, 2026: Short sales 37.3%
  • Nov 16, 2026: Short sales 51%
  • Nov 17, 2026: Short sales 60.4%
  • Nov 18, 2026: Short sales 25.3%
  • Nov 19, 2026: Short sales 10.1%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

19 Managers, Q2 2026$4.8M Value of their positions
  • Q3 2025: Managers 9
  • Q4 2025: Managers 22
  • Q1 2026: Managers 20
  • Q2 2026: Managers 19

Institutional investors by quarter

The fund managers holding BHST, quarter by quarter, from Q4 2024 to Q2 2025, 3 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 7 quarters.

Q2 2026: 19 managers held 1.68M shares, worth $4.8M. During the quarter 2 opened a position, 3 closed one, 6 added and 7 trimmed.

The largest holders, Q2 2026

  • Alyeska Investment Group
    In the quarter-23%
  • Thompson Siegel & Walmsley
    In the quarter-5.9%
  • Evercore Wealth Management
    In the quarter+55%
  • True North Advisors
    In the quarter+11%
  • Magnus Financial Group
    In the quarter+64%
  • Susquehanna International Group
    In the quarter+288%
  • Silverberg Bernstein Capital Management
    In the quarter+121%
  • King Luther Capital Management
    In the quarter
  • TD Waterhouse Canada
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter+40%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do BioHarvest Sciences's filings show?

Who buys and sells is one part of BioHarvest Sciences's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about BHST's shareholders

Didn't find what you were looking for?

Ask us
Have BHST's insiders bought or sold?

From – to – BioHarvest Sciences's insiders reported no purchase or sale of shares on the market.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.